Sequana Medical NV
Research Sequana Medical NV (SEQUA) on Bullrun: market cap EUR 47.76M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSEQUA
- ExchangeBR
- CountryBelgium
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 47.76M
- Financial periodFY2024
- RevenueEUR 105.50K
- Revenue growth-85.2%
- Net income-EUR 44.65M
- Free cash flow-EUR 20.35M
- Gross margin74.9%
Valuation Snapshot
latest market cap is EUR 47.76M.
About Sequana Medical NV
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offers alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body. Sequana Medical NV was founded in 2006 and is headquartered in Gent, Belgium.
Frequently asked questions
What is Sequana Medical NV's market cap?
Sequana Medical NV's market capitalization is EUR 47.76M.
What does Sequana Medical NV do?
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally.